Rad Partners' Nina Kottler, MD, explains what practices should consider when assessing artificial intelligence solutions in an era where there is little reimbursement.  
 

Michael Bruno, MD, vice chair for quality and patient safety at the Penn State Milton S. Hershey Medical Center, discusses two hot topics at RSNA 2023. 

Jamie Bourque, MD, spoke to Cardiovascular Business about the growing number of ways FDG-PET scans are being used in cardiology. This includes evaluating inflammation, tracking EP device infections and much more. 

Monique Rasband, KLAS vice president of strategy and research for imaging, shares the trends she is seeing in the specialty.

Cybersecurity in the healthcare sector has been a growing concern, and medical imaging is one of the largest users of off-site cloud data storage.

David Hur, MD, director of structural heart disease/interventional imaging at the VA Connecticut Healthcare System, and an assistant professor of medicine at Yale, explains the technical challenges encountered in cardiac computed tomography (CT) and how to overcome them.

Robert Hendel, MD, discussed everything from declining reimbursements in cardiology to prior authorization policies in an exclusive new interview. 

The new radiotracer flurpiridaz is poised to make a major impact on nuclear cardiology. Timothy Bateman, MD, co-director of the cardiovascular radiologic imaging program at Saint Luke's Mid America Heart Institute, shared details on the tracer in a new interview.